Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yung Zip Chemical CoROCO:4102 -0.49%63 EBITDA Margin % is 11.48% as of Dec. 2025, which is 9% below its 10-year median of 12.57. GuruFocus rates ROCO:4102 with a GF Score™ of 63/100 and a GF Value™ of NT$24.06 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 959 Drug Manufacturers companies, Yung Zip Chemical Co ranks worse than 65.17% on this metric.
Yung Zip Chemical Co (ROCO:4102) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Yung Zip Chemical Co EBITDA Margin % Related Terms
Yung Zip Chemical Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Yung Zip Chemical Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4102 vs LLY, JNJ, ABBV: EBITDA Margin % Comparison
For the Drug Manufacturers - General subindustry, Yung Zip Chemical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yung Zip Chemical Co EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Yung Zip Chemical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Yung Zip Chemical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yung Zip Chemical Co (ROCO:4102) has a EBITDA Margin % of 11.48% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Yung Zip Chemical Co and its competitors. This is near median its historical median of 12.57. According to the industry distribution chart, Yung Zip Chemical Co ranks #625 out of 959 companies in the Drug Manufacturers industry, placing it in the top 65.2%.
Is Yung Zip Chemical Co's EBITDA Margin % too high?
Yung Zip Chemical Co's current EBITDA Margin % of 11.48% is near median its 10-year median of 12.57. The Drug Manufacturers industry median EBITDA Margin % is 12.54. Yung Zip Chemical Co's value of 11.48% is 8.5% below this industry median. Based on the distribution chart, Yung Zip Chemical Co ranks #625 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Yung Zip Chemical Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yung Zip Chemical Co's EBITDA Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Yung Zip Chemical Co ranks #625 out of 959 companies for EBITDA Margin %. This places Yung Zip Chemical Co in the lower half of its industry. The industry median EBITDA Margin % is 12.54. Yung Zip Chemical Co's value of 11.48% is 8.5% below this benchmark. While the company's 10-year median is 12.57 vs. the industry median of 12.54, Yung Zip Chemical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.54, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yung Zip Chemical Co's current EBITDA Margin % of 11.48% is 8.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Yung Zip Chemical Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yung Zip Chemical Co's current EBITDA Margin % is 11.48%, which is near median its own 10-year median of 12.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yung Zip Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Yung Zip Chemical Co (ROCO:4102) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$24.06, compared to a current price of NT$20.35 — trading 15.4% below its estimated fair value. The current EBITDA Margin % is 11.48%, which is near median its 10-year median of 12.57 and 8.5% below the Drug Manufacturers industry median of 12.54. Yung Zip Chemical Co's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Yung Zip Chemical Co (ROCO:4102), the current EBITDA Margin % is 11.48% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yung Zip Chemical Co (ROCO:4102) Overvalued in 2026?
Based on GuruFocus' analysis, Yung Zip Chemical Co stock appears to be undervalued.
The current stock price of NT$20.35 is trading 15.4% below its estimated GF Value™ of NT$24.06.
GuruFocus considers Yung Zip Chemical Co to be Modestly Undervalued.
Key valuation signals for ROCO:4102:
EBITDA Margin %: 11.48% (near median its 10-year median of 12.57)
GF Value™: NT$24.06 vs. price of NT$20.35 (15.4% below fair value)
Industry Position: 8.5% below the Drug Manufacturers median (#625 of 959)
No single metric tells the full story. See the ROCO:4102 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yung Zip Chemical Co Ltd is a bulk drug manufacturing company. It is engaged in supplying APIs, API intermediates and specialty chemicals, it also provides CRO and CMO services to customers both domestic and international.
63GF Score
Get the complete analysis for ROCO:4102
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4102 has been successfully added to your 
